CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 20 8089 7893 support@capital.com

交易 Teva Pharma Ind Adr Rep 1 - TEVA CFD

10.67
0.09%
0.20
最低: 10.59
最高: 10.73
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.20
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.030779%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.013666%
隔夜费时间 22:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Teva Pharmaceutical Industries Ltd ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 10.66
开盘价* 10.67
1 年变化* 23.07%
日范围* 10.59 - 10.73
52 周范围 6.78-11.45
平均交易量（10 天） 8.25M
平均交易量（3 个月) 194.23M
市值 11.79B
市盈率 -100.00K
流通股 1.11B
收入 15.14B
EPS -1.17
股息（收益率 %） N/A
贝塔 1.21
下一个财报发布日期 Feb 8, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Feb 3, 2023 10.67 0.16 1.52% 10.51 10.76 10.51
Feb 2, 2023 10.66 0.09 0.85% 10.57 10.68 10.47
Feb 1, 2023 10.56 0.11 1.05% 10.45 10.64 10.35
Jan 31, 2023 10.39 0.18 1.76% 10.21 10.67 10.21
Jan 30, 2023 10.21 0.07 0.69% 10.14 10.36 10.05
Jan 27, 2023 10.24 0.10 0.99% 10.14 10.48 10.14
Jan 26, 2023 10.23 0.09 0.89% 10.14 10.27 10.07
Jan 25, 2023 10.15 0.11 1.10% 10.04 10.19 10.02
Jan 24, 2023 10.05 -0.16 -1.57% 10.21 10.32 10.05
Jan 23, 2023 10.33 0.02 0.19% 10.31 10.43 10.20
Jan 20, 2023 10.21 -0.30 -2.85% 10.51 10.59 10.21
Jan 19, 2023 10.47 0.00 0.00% 10.47 10.62 10.23
Jan 18, 2023 10.80 0.00 0.00% 10.80 10.90 10.68
Jan 17, 2023 10.95 -0.15 -1.35% 11.10 11.21 10.92
Jan 13, 2023 11.18 -0.01 -0.09% 11.19 11.27 10.94
Jan 12, 2023 11.26 0.19 1.72% 11.07 11.41 11.02
Jan 11, 2023 10.96 0.02 0.18% 10.94 11.14 10.82
Jan 10, 2023 10.88 0.06 0.55% 10.82 11.01 10.75
Jan 9, 2023 10.78 -0.05 -0.46% 10.83 11.19 10.58
Jan 6, 2023 10.46 0.49 4.91% 9.97 10.69 9.89

Teva Pharma Ind Adr Rep 1 Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
总收入 21903 22385 18854 16887 16659 15878
收入 21903 22385 18854 16887 16659 15878
收入成本，共计 10250 11770 10558 9351 8870 8014
毛利 11653 10615 8296 7536 7789 7864
总营业费用 20631 39911 20537 17330 20231 14162
销售/一般/行政费用，总计 4973 4637 4052 3667 3519 3402
研究与开发 2077 1778 1213 1010 997 967
异常费用（收入） 3286 21520 4838 3191 6739 1721
Other Operating Expenses, Total 45 -3 -286 -28 -20 -41
营业收入 1272 -17526 -1683 -443 -3572 1716
利息收入（费用），非经营净值 -446 -856 -894 -825 -833 -988
其他，净值 -2 3 -19 3 -1 -70
税前净收入 824 -18379 -2596 -1265 -4406 658
税后净收入 303 -17507 -2304 -987 -4238 447
少数股东权益 18 184 322 2 109 -39
Equity In Affiliates 8 -3 -71 -13 138 9
未计算非常项目前的净收益 329 -17326 -2053 -998 -3991 417
非常规项目总计 0 1061 -97 0 0
净收入 329 -16265 -2150 -998 -3991 417
Total Adjustments to Net Income -261 -260 -249 -1 1
普通股股东可获收益 (不含非经常性项目) 68 -17586 -2302 -999 -3990 417
普通股股东可获收益 (含非經常性項目) 68 -16525 -2399 -999 -3990 417
摊薄调整 0
摊薄净收入 68 -16525 -2399 -999 -3990 417
摊薄后加权平均股 961 1016 1021 1091 1095 1107
扣除特别项目的每股摊薄盈利 0.07076 -17.3091 -2.25465 -0.91567 -3.64384 0.37669
Dividends per Share - Common Stock Primary Issue 1.36 0.85 0
每股正常摊薄盈利 2.29537 -3.51127 0.82537 0.98547 0.35648 1.43282
Depreciation / Amortization 209 162 139 126 99
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
总收入 3982 3910 3887 4100 3661
收入 3982 3910 3887 4100 3661
收入成本，共计 2063 1987 1989 1975 1859
毛利 1919 1923 1898 2125 1802
总营业费用 3548 3328 3264 4022 4374
销售/一般/行政费用，总计 848 832 864 858 819
研究与开发 254 243 222 249 225
Depreciation / Amortization 27 25 24 23 22
异常费用（收入） 360 247 183 893 1502
Other Operating Expenses, Total -4 -6 -18 24 -53
营业收入 434 582 623 78 -713
利息收入（费用），非经营净值 -381 -254 -254 -170 -238
其他，净值 91 -20 13 -83 -20
税前净收入 144 308 382 -175 -971
税后净收入 82 210 306 -151 -973
少数股东权益 -7 -14 -11 -7 -3
Equity In Affiliates 3 11 -5 0 21
未计算非常项目前的净收益 78 207 290 -158 -955
净收入 78 207 290 -158 -955
Total Adjustments to Net Income -1 2 -1
普通股股东可获收益 (不含非经常性项目) 77 207 292 -159 -955
普通股股东可获收益 (含非經常性項目) 77 207 292 -159 -955
摊薄净收入 77 207 292 -159 -955
摊薄后加权平均股 1107 1109 1109 1102 1107
扣除特别项目的每股摊薄盈利 0.06956 0.18665 0.2633 -0.14428 -0.86269
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 0.25474 0.33851 0.39548 0.38244 0.01924
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
流动资产总额 17228 15382 13794 13464 13005 12573
现金和短期投资 1667 977 1784 1975 2177 2165
现金等价物 988 963 1782 1975 2177 2165
短期投资 679 14 2
应收账款总额，净额 7523 7128 5822 5676 4581 4529
Accounts Receivable - Trade, Net 7523 7128 5822 5676 4581 4529
Total Inventory 4954 4924 4731 4422 4403 3818
Prepaid Expenses 1629 1100 899 870 945 1075
Other Current Assets, Total 1455 1253 558 521 899 986
Total Assets 93057 70615 60683 57470 50640 47666
Property/Plant/Equipment, Total - Net 8073 7673 6868 6950 6855 6477
Property/Plant/Equipment, Total - Gross 11926 12178 11796 11864 11947 11718
Accumulated Depreciation, Total -3853 -4505 -4928 -4914 -5092 -5241
Goodwill, Net 44409 28414 24917 24846 20624 20040
Intangibles, Net 21487 17640 14005 11232 8923 7466
Other Long Term Assets, Total 1860 1423 1038 978 1233 1110
Total Current Liabilities 18488 17921 14322 13674 13164 11027
Accounts Payable 2157 2069 1853 1718 1756 1686
Accrued Expenses 4264 3563 2738 2680 2581 2880
Notes Payable/Short Term Debt 2466 766 516 514 514 23
Current Port. of LT Debt/Capital Leases 810 2880 1700 1831 2674 1403
Other Current Liabilities, Total 8791 8643 7515 6931 5639 5035
Total Liabilities 59720 53256 45976 43498 40614 37388
Total Long Term Debt 32522 28827 26691 24562 22731 21617
Long Term Debt 32522 28827 26691 24562 22731 21617
Deferred Income Tax 5413 3277 2140 1096 964 784
Minority Interest 1656 1386 1087 1091 1035 966
Other Liabilities, Total 1641 1845 1736 3075 2720 2994
Total Equity 33337 17359 14707 13972 10026 10278
Redeemable Preferred Stock 3620 3631 0
Common Stock 54 54 56 56 57 57
Additional Paid-In Capital 23409 23479 27210 27312 27443 27561
Retained Earnings (Accumulated Deficit) 13607 -3803 -5958 -6956 -10946 -10529
Treasury Stock - Common -4194 -4149 -4142 -4128 -4128 -4128
Unrealized Gain (Loss) -7 -4 1 0 0 0
Other Equity, Total -3152 -1849 -2460 -2312 -2400 -2683
Total Liabilities & Shareholders’ Equity 93057 70615 60683 57470 50640 47666
Total Common Shares Outstanding 1014.99 1016.88 1089.39 1092.19 1096.51 1103.33
Total Preferred Shares Outstanding 3.7 3.7 0 0 0
Long Term Investments 83 61
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流动资产总额 12401 12822 12154 12573 12451
现金和短期投资 1743 2436 2045 2165 2175
现金等价物 1743 2436 2045 2165 2175
应收账款总额，净额 4572 4488 4046 4529 4253
Accounts Receivable - Trade, Net 4572 4488 4046 4529 4253
Total Inventory 4406 4362 4167 3818 4012
Prepaid Expenses 942 1022 1066 1075 1064
Other Current Assets, Total 738 514 830 986 947
Total Assets 49004 49195 47851 47666 47059
Property/Plant/Equipment, Total - Net 6641 6658 6547 6477 6396
Goodwill, Net 20302 20421 20179 20040 19986
Intangibles, Net 8445 8120 7832 7466 7116
Other Long Term Assets, Total 1215 1174 1139 1110 1110
Total Current Liabilities 12089 12691 11825 11027 11613
Accounts Payable 1692 1551 1514 1686 1750
Accrued Expenses 2377 2318 2590 2771 3078
Notes Payable/Short Term Debt 23 23 323 23 23
Current Port. of LT Debt/Capital Leases 2674 3507 2386 1403 2054
Other Current Liabilities, Total 5323 5292 5012 5144 4708
Total Liabilities 39004 38871 37384 37388 37715
Total Long Term Debt 22288 21602 21037 21617 20840
Long Term Debt 22288 21602 21037 21617 20840
Deferred Income Tax 991 932 910 784 666
Minority Interest 975 987 984 966 916
Other Liabilities, Total 2661 2659 2628 2994 3680
Total Equity 10000 10324 10467 10278 9344
Common Stock 57 57 57 57 57
Additional Paid-In Capital 27474 27503 27529 27561 27587
Retained Earnings (Accumulated Deficit) -10869 -10662 -10370 -10529 -11484
Treasury Stock - Common -4128 -4128 -4128 -4128 -4128
Other Equity, Total -2534 -2446 -2621 -2683 -2688
Total Liabilities & Shareholders’ Equity 49004 49195 47851 47666 47059
Total Common Shares Outstanding 1102.35 1102.89 1103.01 1103.33 1110.35
Total Preferred Shares Outstanding 0
Unrealized Gain (Loss) 0
  • 年度
  • 每季度
2016 2017 2018 2019 2020 2021
净收入/起跑线 311 -16449 -2472 -1000 -4099 456
经营活动产生的现金 3890 2225 2446 748 1216 798
经营活动产生的现金 1524 2112 1842 1722 1557 1330
Deferred Taxes 15 -2331 -837 -985 -696 -120
非现金物品 2156 20538 5736 1907 6642 833
Cash Taxes Paid 341 106 420 552 709 495
已付现金利息 290 795 815 840 846 913
营运资金的变化 -116 -1645 -1823 -896 -2188 -1701
投资活动产生的现金 -34405 3446 1866 1355 863 1523
资本支出 -901 -874 -651 -525 -578 -562
其他投资现金流量项目，总计 -33504 4320 2517 1880 1441 2085
融资活动产生的现金 25217 -5750 -3351 -1926 -1885 -2172
融资现金流项目 -169 -112 -57 -11 -5 -6
Total Cash Dividends Paid -1558 -1161 -22 -52 0 0
股票的发行（报废），净额 693 0 0
债务的发行（退还），净额 26251 -4477 -3272 -1863 -1880 -2166
外汇效应 -660 54 -142 16 8 -128
现金净变化 -5958 -25 819 193 202 21
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 84 306 608 456 -952
Cash From Operating Activities -405 -187 342 798 -49
Cash From Operating Activities 376 681 1010 1330 323
Deferred Taxes -11 5 13 -120 -175
Non-Cash Items 222 500 592 833 196
Changes in Working Capital -1076 -1679 -1881 -1701 559
Cash From Investing Activities 508 989 1277 1523 161
Capital Expenditures -150 -263 -409 -562 -157
Other Investing Cash Flow Items, Total 658 1252 1686 2085 318
Cash From Financing Activities -493 -494 -1671 -2172 2
Financing Cash Flow Items -2 -3 -5 -6 2
Issuance (Retirement) of Debt, Net -491 -491 -1666 -2166 0
Foreign Exchange Effects -44 -49 -80 -128 -62
Net Change in Cash -434 259 -132 21 52
Total Cash Dividends Paid 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Capital Research Global Investors Investment Advisor 10.5524 117190328 24024045 2022-09-30 LOW
Capital World Investors Investment Advisor 3.5415 39329765 39329765 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.8455 31600577 -827744 2022-09-30 LOW
Abrams Capital, L.L.C. Hedge Fund 2.152 23899296 -147060 2022-09-30 LOW
Menora Mivtachim Insurance Ltd. Insurance Company 2.0987 23307560 -3050 2022-09-30 LOW
Migdal Insurance and Financial Holdings Ltd Insurance Company 1.9447 21596560 216360 2022-12-31 MED
Phoenix Holdings Ltd Holding Company 1.8757 20831080 2301291 2022-09-30 MED
Clal Insurance Enterprises Holdings Ltd. Investment Advisor 1.7475 19406766 444000 2022-09-30 LOW
Harel Insurance Investments and Financial Services Ltd Investment Advisor 1.3613 15118229 985502 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3418 14901933 1055920 2022-09-30 LOW
EXOR Investments (UK) LLP Investment Advisor 1.0375 11522187 11522187 2022-09-30 LOW
Capital International Investors Investment Advisor 0.9613 10675231 -7647 2022-09-30 LOW
Miller Value Partners, LLC Investment Advisor 0.8334 9254875 -79715 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7338 8148857 126299 2022-09-30 LOW
Two Sigma Investments, LP Hedge Fund 0.7189 7983801 5844332 2022-09-30 HIGH
Beck, Mack & Oliver LLC Investment Advisor 0.6787 7536985 1072190 2022-09-30 LOW
Camber Capital Management LP Hedge Fund 0.6753 7500000 4750000 2022-09-30 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5973 6633114 314715 2022-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.4259 4730246 -881152 2022-09-30 LOW
Schweizerische Nationalbank Bank and Trust 0.4247 4716093 27700 2022-09-30 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group
+485000+

交易者

65000+

每月活跃客户

$48000000+

每月投资额

$28000000+

每月提取金额

交易計算器

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

貿易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
杠杆
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Teva Company profile

关于 Teva Pharmaceutical Industries Ltd (ADR)

梯瓦制药工业有限公司是一家位于以色列的制药公司。 该公司通过三个部分运营。 北美、欧洲和国际市场。 每个业务部门管理其所在地区的全部产品组合，包括非专利药、专业药和非处方药（OTC）产品。 除了这三个部分，公司还有其他业务，主要是向第三方销售活性药物成分（API），某些合同生产服务，以及通过其关联公司Medis向其他制药公司提供产品组合的对外授权平台。

Industry: Pharmaceuticals (NEC)

5 Bazel St
P O B 3190
PETAH TIKVA
49131
IL

收入报表

  • Annual
  • Quarterly

人们也观看

BTC/USD

22,888.35 Price
-0.130% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 60.00

Oil - Crude

74.10 Price
+0.900% 1D Chg, %
多头隔夜费 -0.0222%
空头隔夜费 0.0064%
隔夜费时间 22:00 (UTC)
价差 0.03

XRP/USD

0.40 Price
+0.140% 1D Chg, %
多头隔夜费 -0.0500%
空头隔夜费 0.0140%
隔夜费时间 22:00 (UTC)
价差 0.00330

Natural Gas

2.43 Price
+0.620% 1D Chg, %
多头隔夜费 -0.1132%
空头隔夜费 0.0792%
隔夜费时间 22:00 (UTC)
价差 0.005

还在找一位您可以信任的经纪商吗？

加入成为全球485,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易